Investigation Overview
May 11, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Intermolecular Inc (NASDAQ:IMI) was announced over potential breaches of fiduciary duties by certain officers and directors at Intermolecular Inc.
The investigation by a law firm concerns whether certain Intermolecular officers and directors breached their fiduciary duties.
Intermolecular Inc reported that its annual Total Revenue declined from $47.70 million in 2014 to $45.32 million in 2015 and that its Net Loss declined from $21.76 million in 2014 to $21.01 million in 2015.
Shares of Intermolecular Inc (NASDAQ:IMI) declined from $10.39 per share in March 2013 to as low as $1.61 per share in March 2015.
On May 11, 2016, NASDAQ:IMI shares closed at $2.00 per share.